1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study.
(
- Contribution to journal › Article
- 2003
-
Mark
Induction of operational tolerance to discordant dopaminergic porcine xenografts.
(
- Contribution to journal › Article
- 2002
-
Mark
Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L.
(
- Contribution to journal › Article
-
Mark
CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice.
(
- Contribution to journal › Article
-
Mark
Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
(
- Contribution to journal › Article
-
Mark
CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely.
(
- Contribution to journal › Article